Amaza Reitmeier and Ashwini Sharan, MD, gave clinical perspectives on the CE Mark approval for Medtronic’s BrainSense Adaptive DBS and Electrode Identifier, 2 technologies geared towards patients with Parkinson disease.:
Source: Neurology Read More
Innovating Parkinson’s Care: Key Takeaways from the CE Mark Approval of BrainSense aDBS
Related Posts
<![CDATA[Votoplam Shows Dose-Dependent Slowing of
Disease Progression in Stage 2 Huntington Disease]]>
<![CDATA[Votoplam Shows Dose-Dependent Slowing of Disease Progression in Stage 2 Huntington Disease]]>
